A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status

INTRODUCTION: Limited data exist on real-world treatment patterns and the effectiveness of cyclin-dependent kinase (CDK) 4/6 inhibitors in germline BRCA (gBRCA)-mutated breast cancer. METHODS: Adults with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Jenna M., Nordstrom, Beth L., McLaurin, Kimmie K., Dalvi, Tapashi B., McCutcheon, Susan C., Bennett, James C., Murphy, Brian R., Singhal, Puneet K., McCrea, Charles, Shinde, Reshma, Briceno, Josefa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593114/
https://www.ncbi.nlm.nih.gov/pubmed/34308518
http://dx.doi.org/10.1007/s40487-021-00162-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593114/
https://www.ncbi.nlm.nih.gov/pubmed/34308518
http://dx.doi.org/10.1007/s40487-021-00162-4

Ejemplares similares